Lactam inhibitors are provided which have the structure
1
including pharmaceutically acceptable salts thereof and all stereoisomers thereof, and prodrug esters thereof, wherein n is 1 to 5; and
and R
1
, R
2
, R
3
, R
4
, R
5
, R
6
, R
7
, R
8
, R
9
, R
10
, R
10a
, 10
11
and R
12
are as defined herein. These compounds are inhibitors of Factor Xa and thus are useful as anticoagulants. A method for treating cardiovascular diseases associated with thromboses is also provided.
AGENTS AND METHODS FOR TREATING ISCHEMIC AND OTHER DISEASES
申请人:Sun Xiujun
公开号:US20110251182A1
公开(公告)日:2011-10-13
This invention relates to methods of screening for modulators of mammalian cell injury cause by TRPM7 gene and protein activity, compounds that modulate TRPM7 gene and protein activity and methods of treatment of mammalian cell injury using modulators of TRPM7 gene and protein activity.
US9566284B2
申请人:——
公开号:US9566284B2
公开(公告)日:2017-02-14
Dominguez; Basante; Charris, Il Farmaco, 1996, vol. 51, # 6, p. 407 - 412